Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Mayo Clinic is betting big on AI — and its next CEO reflects that. Dr. Matthew Callstrom, who currently leads the health system's strategy and generative AI programs, will become president and CEO on January 1, succeeding Dr. Gianrico Farrugia. Callstrom has been with Mayo since 2002 and has been central to its push to weave AI into clinical care and drug discovery.
Mayo Clinic is handing the keys to one of its most tech-forward leaders. Dr. Matthew Callstrom, currently the medical director overseeing strategy and the generative AI program at Mayo Clinic, will step into the role of president and CEO on January 1, 2027. He succeeds Dr. Gianrico Farrugia, who led the health system for eight years before announcing his departure earlier this year.
Callstrom is no newcomer — he's been with Mayo since 2002, building expertise across clinical practice, research, strategy, and AI. In his current role, he's been instrumental in shaping how Mayo integrates AI into medicine, from identifying new drugs to detecting diseases earlier and supporting clinical decision-making. Mayo has long been one of healthcare's most prominent AI adopters, and Callstrom's appointment signals the health system plans to double down on that identity.
Key Takeaways:
Why it matters: Leadership transitions at major health systems set the tone for the broader industry. With an AI strategist at the helm of one of the world's most influential hospitals, expect Mayo Clinic — and potentially its peers — to push even harder on integrating artificial intelligence into everyday clinical care.